ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gene Recombinant Protein Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-9U17285
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Gene Recombinant Protein Market Research Report 2024
BUY CHAPTERS

Global Gene Recombinant Protein Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-9U17285
Report
November 2025
Pages:146
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Eurogentec S.A
GenScript
OriGene
Sino Biological
Abgenex
Promega
Bio-Techne
Merck KGaA
Abcam
Cytiva
Abnova Corporation
Ajinomoto
Miltenyi Biotec
Bio Techne Corporation
ACROBiosystems
Reprocell
BPS Bioscience
Prospec-Tany Technogene

Gene Recombinant Protein Market

The global Gene Recombinant Protein market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Genetically recombinant protein is a protein produced using genetic engineering technology.
From a downstream perspective, Pharmaceutical accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Gene Recombinant Protein leading manufacturers including Thermo Fisher Scientific, Eurogentec, GenScript, OriGene, Sino Biological, Abgenex, Promega, Bio - Techne, Merck KGaA, Abcam PLC, etc., dominate supply; the top five capture approximately % of global revenue, with Thermo Fisher Scientific leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Gene Recombinant Protein market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Gene Recombinant Protein Market Report

Report Metric Details
Report Name Gene Recombinant Protein Market
Segment by Type
  • Cytokines
  • Plasma Protein Factors
  • Recombinant Hormone
  • Interferon
  • Growth Factors
  • Clotting Factor
  • Enzyme
  • Others
Segment by Application
  • Pharmaceutical
  • Scientific Research
  • Cosmetic
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, Eurogentec, GenScript, OriGene, Sino Biological, Abgenex, Promega, Bio - Techne, Merck KGaA, Abcam PLC, Cytiva, Abnova Corporation, Ajinomoto, Miltenyi Biotec, Bio-Techne Corporation, ACROBiosystems, Reprocell, BPS Bioscience, ProSpec Tany TechnoGene
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Gene Recombinant Protein study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Gene Recombinant Protein Market report?

Ans: The main players in the Gene Recombinant Protein Market are Thermo Fisher Scientific, Eurogentec, GenScript, OriGene, Sino Biological, Abgenex, Promega, Bio - Techne, Merck KGaA, Abcam PLC, Cytiva, Abnova Corporation, Ajinomoto, Miltenyi Biotec, Bio-Techne Corporation, ACROBiosystems, Reprocell, BPS Bioscience, ProSpec Tany TechnoGene

What are the Application segmentation covered in the Gene Recombinant Protein Market report?

Ans: The Applications covered in the Gene Recombinant Protein Market report are Pharmaceutical, Scientific Research, Cosmetic, Others

What are the Type segmentation covered in the Gene Recombinant Protein Market report?

Ans: The Types covered in the Gene Recombinant Protein Market report are Cytokines, Plasma Protein Factors, Recombinant Hormone, Interferon, Growth Factors, Clotting Factor, Enzyme, Others

1 Study Coverage
1.1 Introduction to Gene Recombinant Protein: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Gene Recombinant Protein Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Cytokines
1.2.3 Plasma Protein Factors
1.2.4 Recombinant Hormone
1.2.5 Interferon
1.2.6 Growth Factors
1.2.7 Clotting Factor
1.2.8 Enzyme
1.2.9 Others
1.3 Market Segmentation by Application
1.3.1 Global Gene Recombinant Protein Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Scientific Research
1.3.4 Cosmetic
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Gene Recombinant Protein Revenue Estimates and Forecasts 2020-2031
2.2 Global Gene Recombinant Protein Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Gene Recombinant Protein Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Gene Recombinant Protein Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Cytokines Market Size by Players
3.3.2 Plasma Protein Factors Market Size by Players
3.3.3 Recombinant Hormone Market Size by Players
3.3.4 Interferon Market Size by Players
3.3.5 Growth Factors Market Size by Players
3.3.6 Clotting Factor Market Size by Players
3.3.7 Enzyme Market Size by Players
3.3.8 Others Market Size by Players
3.4 Global Gene Recombinant Protein Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Gene Recombinant Protein Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Gene Recombinant Protein Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Gene Recombinant Protein Market Size by Type (2020-2031)
6.4 North America Gene Recombinant Protein Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Gene Recombinant Protein Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Gene Recombinant Protein Market Size by Type (2020-2031)
7.4 Europe Gene Recombinant Protein Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Gene Recombinant Protein Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Gene Recombinant Protein Market Size by Type (2020-2031)
8.4 Asia-Pacific Gene Recombinant Protein Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Gene Recombinant Protein Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Gene Recombinant Protein Market Size by Type (2020-2031)
9.4 Central and South America Gene Recombinant Protein Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Gene Recombinant Protein Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Gene Recombinant Protein Market Size by Type (2020-2031)
10.4 Middle East and Africa Gene Recombinant Protein Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Gene Recombinant Protein Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Corporation Information
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Gene Recombinant Protein Product Features and Attributes
11.1.4 Thermo Fisher Scientific Gene Recombinant Protein Revenue and Gross Margin (2020-2025)
11.1.5 Thermo Fisher Scientific Gene Recombinant Protein Revenue by Product in 2024
11.1.6 Thermo Fisher Scientific Gene Recombinant Protein Revenue by Application in 2024
11.1.7 Thermo Fisher Scientific Gene Recombinant Protein Revenue by Geographic Area in 2024
11.1.8 Thermo Fisher Scientific Gene Recombinant Protein SWOT Analysis
11.1.9 Thermo Fisher Scientific Recent Developments
11.2 Eurogentec
11.2.1 Eurogentec Corporation Information
11.2.2 Eurogentec Business Overview
11.2.3 Eurogentec Gene Recombinant Protein Product Features and Attributes
11.2.4 Eurogentec Gene Recombinant Protein Revenue and Gross Margin (2020-2025)
11.2.5 Eurogentec Gene Recombinant Protein Revenue by Product in 2024
11.2.6 Eurogentec Gene Recombinant Protein Revenue by Application in 2024
11.2.7 Eurogentec Gene Recombinant Protein Revenue by Geographic Area in 2024
11.2.8 Eurogentec Gene Recombinant Protein SWOT Analysis
11.2.9 Eurogentec Recent Developments
11.3 GenScript
11.3.1 GenScript Corporation Information
11.3.2 GenScript Business Overview
11.3.3 GenScript Gene Recombinant Protein Product Features and Attributes
11.3.4 GenScript Gene Recombinant Protein Revenue and Gross Margin (2020-2025)
11.3.5 GenScript Gene Recombinant Protein Revenue by Product in 2024
11.3.6 GenScript Gene Recombinant Protein Revenue by Application in 2024
11.3.7 GenScript Gene Recombinant Protein Revenue by Geographic Area in 2024
11.3.8 GenScript Gene Recombinant Protein SWOT Analysis
11.3.9 GenScript Recent Developments
11.4 OriGene
11.4.1 OriGene Corporation Information
11.4.2 OriGene Business Overview
11.4.3 OriGene Gene Recombinant Protein Product Features and Attributes
11.4.4 OriGene Gene Recombinant Protein Revenue and Gross Margin (2020-2025)
11.4.5 OriGene Gene Recombinant Protein Revenue by Product in 2024
11.4.6 OriGene Gene Recombinant Protein Revenue by Application in 2024
11.4.7 OriGene Gene Recombinant Protein Revenue by Geographic Area in 2024
11.4.8 OriGene Gene Recombinant Protein SWOT Analysis
11.4.9 OriGene Recent Developments
11.5 Sino Biological
11.5.1 Sino Biological Corporation Information
11.5.2 Sino Biological Business Overview
11.5.3 Sino Biological Gene Recombinant Protein Product Features and Attributes
11.5.4 Sino Biological Gene Recombinant Protein Revenue and Gross Margin (2020-2025)
11.5.5 Sino Biological Gene Recombinant Protein Revenue by Product in 2024
11.5.6 Sino Biological Gene Recombinant Protein Revenue by Application in 2024
11.5.7 Sino Biological Gene Recombinant Protein Revenue by Geographic Area in 2024
11.5.8 Sino Biological Gene Recombinant Protein SWOT Analysis
11.5.9 Sino Biological Recent Developments
11.6 Abgenex
11.6.1 Abgenex Corporation Information
11.6.2 Abgenex Business Overview
11.6.3 Abgenex Gene Recombinant Protein Product Features and Attributes
11.6.4 Abgenex Gene Recombinant Protein Revenue and Gross Margin (2020-2025)
11.6.5 Abgenex Recent Developments
11.7 Promega
11.7.1 Promega Corporation Information
11.7.2 Promega Business Overview
11.7.3 Promega Gene Recombinant Protein Product Features and Attributes
11.7.4 Promega Gene Recombinant Protein Revenue and Gross Margin (2020-2025)
11.7.5 Promega Recent Developments
11.8 Bio - Techne
11.8.1 Bio - Techne Corporation Information
11.8.2 Bio - Techne Business Overview
11.8.3 Bio - Techne Gene Recombinant Protein Product Features and Attributes
11.8.4 Bio - Techne Gene Recombinant Protein Revenue and Gross Margin (2020-2025)
11.8.5 Bio - Techne Recent Developments
11.9 Merck KGaA
11.9.1 Merck KGaA Corporation Information
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Gene Recombinant Protein Product Features and Attributes
11.9.4 Merck KGaA Gene Recombinant Protein Revenue and Gross Margin (2020-2025)
11.9.5 Merck KGaA Recent Developments
11.10 Abcam PLC
11.10.1 Abcam PLC Corporation Information
11.10.2 Abcam PLC Business Overview
11.10.3 Abcam PLC Gene Recombinant Protein Product Features and Attributes
11.10.4 Abcam PLC Gene Recombinant Protein Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Cytiva
11.11.1 Cytiva Corporation Information
11.11.2 Cytiva Business Overview
11.11.3 Cytiva Gene Recombinant Protein Product Features and Attributes
11.11.4 Cytiva Gene Recombinant Protein Revenue and Gross Margin (2020-2025)
11.11.5 Cytiva Recent Developments
11.12 Abnova Corporation
11.12.1 Abnova Corporation Corporation Information
11.12.2 Abnova Corporation Business Overview
11.12.3 Abnova Corporation Gene Recombinant Protein Product Features and Attributes
11.12.4 Abnova Corporation Gene Recombinant Protein Revenue and Gross Margin (2020-2025)
11.12.5 Abnova Corporation Recent Developments
11.13 Ajinomoto
11.13.1 Ajinomoto Corporation Information
11.13.2 Ajinomoto Business Overview
11.13.3 Ajinomoto Gene Recombinant Protein Product Features and Attributes
11.13.4 Ajinomoto Gene Recombinant Protein Revenue and Gross Margin (2020-2025)
11.13.5 Ajinomoto Recent Developments
11.14 Miltenyi Biotec
11.14.1 Miltenyi Biotec Corporation Information
11.14.2 Miltenyi Biotec Business Overview
11.14.3 Miltenyi Biotec Gene Recombinant Protein Product Features and Attributes
11.14.4 Miltenyi Biotec Gene Recombinant Protein Revenue and Gross Margin (2020-2025)
11.14.5 Miltenyi Biotec Recent Developments
11.15 Bio-Techne Corporation
11.15.1 Bio-Techne Corporation Corporation Information
11.15.2 Bio-Techne Corporation Business Overview
11.15.3 Bio-Techne Corporation Gene Recombinant Protein Product Features and Attributes
11.15.4 Bio-Techne Corporation Gene Recombinant Protein Revenue and Gross Margin (2020-2025)
11.15.5 Bio-Techne Corporation Recent Developments
11.16 ACROBiosystems
11.16.1 ACROBiosystems Corporation Information
11.16.2 ACROBiosystems Business Overview
11.16.3 ACROBiosystems Gene Recombinant Protein Product Features and Attributes
11.16.4 ACROBiosystems Gene Recombinant Protein Revenue and Gross Margin (2020-2025)
11.16.5 ACROBiosystems Recent Developments
11.17 Reprocell
11.17.1 Reprocell Corporation Information
11.17.2 Reprocell Business Overview
11.17.3 Reprocell Gene Recombinant Protein Product Features and Attributes
11.17.4 Reprocell Gene Recombinant Protein Revenue and Gross Margin (2020-2025)
11.17.5 Reprocell Recent Developments
11.18 BPS Bioscience
11.18.1 BPS Bioscience Corporation Information
11.18.2 BPS Bioscience Business Overview
11.18.3 BPS Bioscience Gene Recombinant Protein Product Features and Attributes
11.18.4 BPS Bioscience Gene Recombinant Protein Revenue and Gross Margin (2020-2025)
11.18.5 BPS Bioscience Recent Developments
11.19 ProSpec Tany TechnoGene
11.19.1 ProSpec Tany TechnoGene Corporation Information
11.19.2 ProSpec Tany TechnoGene Business Overview
11.19.3 ProSpec Tany TechnoGene Gene Recombinant Protein Product Features and Attributes
11.19.4 ProSpec Tany TechnoGene Gene Recombinant Protein Revenue and Gross Margin (2020-2025)
11.19.5 ProSpec Tany TechnoGene Recent Developments
12 Gene Recombinant ProteinIndustry Chain Analysis
12.1 Gene Recombinant Protein Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Gene Recombinant Protein Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Gene Recombinant Protein Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Eurogentec S.A
GenScript
OriGene
Sino Biological
Abgenex
Promega
Bio-Techne
Merck KGaA
Abcam
Cytiva
Abnova Corporation
Ajinomoto
Miltenyi Biotec
Bio Techne Corporation
ACROBiosystems
Reprocell
BPS Bioscience
Prospec-Tany Technogene
List of Tables
 Table 1. Global Gene Recombinant Protein Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Gene Recombinant Protein Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Gene Recombinant Protein Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Gene Recombinant Protein Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Gene Recombinant Protein Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Gene Recombinant Protein Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Gene Recombinant Protein Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Gene Recombinant Protein by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Recombinant Protein as of 2024)
 Table 11. Global Gene Recombinant Protein Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Gene Recombinant Protein Companies Headquarters
 Table 13. Global Gene Recombinant Protein Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Gene Recombinant Protein Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Gene Recombinant Protein Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Gene Recombinant Protein Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Gene Recombinant Protein Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Gene Recombinant Protein High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Gene Recombinant Protein Growth Accelerators and Market Barriers
 Table 25. North America Gene Recombinant Protein Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Gene Recombinant Protein Growth Accelerators and Market Barriers
 Table 27. Europe Gene Recombinant Protein Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Gene Recombinant Protein Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Gene Recombinant Protein Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Gene Recombinant Protein Investment Opportunities and Key Challenges
 Table 31. Central and South America Gene Recombinant Protein Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Gene Recombinant Protein Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Gene Recombinant Protein Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Thermo Fisher Scientific Corporation Information
 Table 35. Thermo Fisher Scientific Description and Major Businesses
 Table 36. Thermo Fisher Scientific Product Features and Attributes
 Table 37. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Thermo Fisher Scientific Revenue Proportion by Product in 2024
 Table 39. Thermo Fisher Scientific Revenue Proportion by Application in 2024
 Table 40. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2024
 Table 41. Thermo Fisher Scientific Gene Recombinant Protein SWOT Analysis
 Table 42. Thermo Fisher Scientific Recent Developments
 Table 43. Eurogentec Corporation Information
 Table 44. Eurogentec Description and Major Businesses
 Table 45. Eurogentec Product Features and Attributes
 Table 46. Eurogentec Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Eurogentec Revenue Proportion by Product in 2024
 Table 48. Eurogentec Revenue Proportion by Application in 2024
 Table 49. Eurogentec Revenue Proportion by Geographic Area in 2024
 Table 50. Eurogentec Gene Recombinant Protein SWOT Analysis
 Table 51. Eurogentec Recent Developments
 Table 52. GenScript Corporation Information
 Table 53. GenScript Description and Major Businesses
 Table 54. GenScript Product Features and Attributes
 Table 55. GenScript Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. GenScript Revenue Proportion by Product in 2024
 Table 57. GenScript Revenue Proportion by Application in 2024
 Table 58. GenScript Revenue Proportion by Geographic Area in 2024
 Table 59. GenScript Gene Recombinant Protein SWOT Analysis
 Table 60. GenScript Recent Developments
 Table 61. OriGene Corporation Information
 Table 62. OriGene Description and Major Businesses
 Table 63. OriGene Product Features and Attributes
 Table 64. OriGene Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. OriGene Revenue Proportion by Product in 2024
 Table 66. OriGene Revenue Proportion by Application in 2024
 Table 67. OriGene Revenue Proportion by Geographic Area in 2024
 Table 68. OriGene Gene Recombinant Protein SWOT Analysis
 Table 69. OriGene Recent Developments
 Table 70. Sino Biological Corporation Information
 Table 71. Sino Biological Description and Major Businesses
 Table 72. Sino Biological Product Features and Attributes
 Table 73. Sino Biological Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Sino Biological Revenue Proportion by Product in 2024
 Table 75. Sino Biological Revenue Proportion by Application in 2024
 Table 76. Sino Biological Revenue Proportion by Geographic Area in 2024
 Table 77. Sino Biological Gene Recombinant Protein SWOT Analysis
 Table 78. Sino Biological Recent Developments
 Table 79. Abgenex Corporation Information
 Table 80. Abgenex Description and Major Businesses
 Table 81. Abgenex Product Features and Attributes
 Table 82. Abgenex Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Abgenex Recent Developments
 Table 84. Promega Corporation Information
 Table 85. Promega Description and Major Businesses
 Table 86. Promega Product Features and Attributes
 Table 87. Promega Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Promega Recent Developments
 Table 89. Bio - Techne Corporation Information
 Table 90. Bio - Techne Description and Major Businesses
 Table 91. Bio - Techne Product Features and Attributes
 Table 92. Bio - Techne Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Bio - Techne Recent Developments
 Table 94. Merck KGaA Corporation Information
 Table 95. Merck KGaA Description and Major Businesses
 Table 96. Merck KGaA Product Features and Attributes
 Table 97. Merck KGaA Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Merck KGaA Recent Developments
 Table 99. Abcam PLC Corporation Information
 Table 100. Abcam PLC Description and Major Businesses
 Table 101. Abcam PLC Product Features and Attributes
 Table 102. Abcam PLC Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Abcam PLC Recent Developments
 Table 104. Cytiva Corporation Information
 Table 105. Cytiva Description and Major Businesses
 Table 106. Cytiva Product Features and Attributes
 Table 107. Cytiva Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Cytiva Recent Developments
 Table 109. Abnova Corporation Corporation Information
 Table 110. Abnova Corporation Description and Major Businesses
 Table 111. Abnova Corporation Product Features and Attributes
 Table 112. Abnova Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Abnova Corporation Recent Developments
 Table 114. Ajinomoto Corporation Information
 Table 115. Ajinomoto Description and Major Businesses
 Table 116. Ajinomoto Product Features and Attributes
 Table 117. Ajinomoto Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. Ajinomoto Recent Developments
 Table 119. Miltenyi Biotec Corporation Information
 Table 120. Miltenyi Biotec Description and Major Businesses
 Table 121. Miltenyi Biotec Product Features and Attributes
 Table 122. Miltenyi Biotec Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. Miltenyi Biotec Recent Developments
 Table 124. Bio-Techne Corporation Corporation Information
 Table 125. Bio-Techne Corporation Description and Major Businesses
 Table 126. Bio-Techne Corporation Product Features and Attributes
 Table 127. Bio-Techne Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. Bio-Techne Corporation Recent Developments
 Table 129. ACROBiosystems Corporation Information
 Table 130. ACROBiosystems Description and Major Businesses
 Table 131. ACROBiosystems Product Features and Attributes
 Table 132. ACROBiosystems Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. ACROBiosystems Recent Developments
 Table 134. Reprocell Corporation Information
 Table 135. Reprocell Description and Major Businesses
 Table 136. Reprocell Product Features and Attributes
 Table 137. Reprocell Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 138. Reprocell Recent Developments
 Table 139. BPS Bioscience Corporation Information
 Table 140. BPS Bioscience Description and Major Businesses
 Table 141. BPS Bioscience Product Features and Attributes
 Table 142. BPS Bioscience Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 143. BPS Bioscience Recent Developments
 Table 144. ProSpec Tany TechnoGene Corporation Information
 Table 145. ProSpec Tany TechnoGene Description and Major Businesses
 Table 146. ProSpec Tany TechnoGene Product Features and Attributes
 Table 147. ProSpec Tany TechnoGene Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 148. ProSpec Tany TechnoGene Recent Developments
 Table 149. Raw Materials Key Suppliers
 Table 150. Distributors List
 Table 151. Market Trends and Market Evolution
 Table 152. Market Drivers and Opportunities
 Table 153. Market Challenges, Risks, and Restraints
 Table 154. Research Programs/Design for This Report
 Table 155. Key Data Information from Secondary Sources
 Table 156. Key Data Information from Primary Sources


List of Figures
 Figure 1. Gene Recombinant Protein Product Picture
 Figure 2. Global Gene Recombinant Protein Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Cytokines Product Picture
 Figure 4. Plasma Protein Factors Product Picture
 Figure 5. Recombinant Hormone Product Picture
 Figure 6. Interferon Product Picture
 Figure 7. Growth Factors Product Picture
 Figure 8. Clotting Factor Product Picture
 Figure 9. Enzyme Product Picture
 Figure 10. Others Product Picture
 Figure 11. Global Gene Recombinant Protein Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Pharmaceutical
 Figure 13. Scientific Research
 Figure 14. Cosmetic
 Figure 15. Others
 Figure 16. Gene Recombinant Protein Report Years Considered
 Figure 17. Global Gene Recombinant Protein Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Gene Recombinant Protein Revenue (2020-2031) & (US$ Million)
 Figure 19. Global Gene Recombinant Protein Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 20. Global Gene Recombinant Protein Revenue Market Share by Region (2020-2031)
 Figure 21. Global Gene Recombinant Protein Revenue Market Share Ranking (2024)
 Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 23. Cytokines Revenue Market Share by Player in 2024
 Figure 24. Plasma Protein Factors Revenue Market Share by Player in 2024
 Figure 25. Recombinant Hormone Revenue Market Share by Player in 2024
 Figure 26. Interferon Revenue Market Share by Player in 2024
 Figure 27. Growth Factors Revenue Market Share by Player in 2024
 Figure 28. Clotting Factor Revenue Market Share by Player in 2024
 Figure 29. Enzyme Revenue Market Share by Player in 2024
 Figure 30. Others Revenue Market Share by Player in 2024
 Figure 31. Global Gene Recombinant Protein Revenue Market Share by Type (2020-2031)
 Figure 32. Global Gene Recombinant Protein Revenue Market Share by Application (2020-2031)
 Figure 33. North America Gene Recombinant Protein Revenue YoY (2020-2031) & (US$ Million)
 Figure 34. North America Top 5 Players Gene Recombinant Protein Revenue (US$ Million) in 2024
 Figure 35. North America Gene Recombinant Protein Revenue (US$ Million) by Type (2020 - 2031)
 Figure 36. North America Gene Recombinant Protein Revenue (US$ Million) by Application (2020-2031)
 Figure 37. US Gene Recombinant Protein Revenue (2020-2031) & (US$ Million)
 Figure 38. Canada Gene Recombinant Protein Revenue (2020-2031) & (US$ Million)
 Figure 39. Mexico Gene Recombinant Protein Revenue (2020-2031) & (US$ Million)
 Figure 40. Europe Gene Recombinant Protein Revenue YoY (2020-2031) & (US$ Million)
 Figure 41. Europe Top 5 Players Gene Recombinant Protein Revenue (US$ Million) in 2024
 Figure 42. Europe Gene Recombinant Protein Revenue (US$ Million) by Type (2020-2031)
 Figure 43. Europe Gene Recombinant Protein Revenue (US$ Million) by Application (2020-2031)
 Figure 44. Germany Gene Recombinant Protein Revenue (2020-2031) & (US$ Million)
 Figure 45. France Gene Recombinant Protein Revenue (2020-2031) & (US$ Million)
 Figure 46. U.K. Gene Recombinant Protein Revenue (2020-2031) & (US$ Million)
 Figure 47. Italy Gene Recombinant Protein Revenue (2020-2031) & (US$ Million)
 Figure 48. Russia Gene Recombinant Protein Revenue (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Gene Recombinant Protein Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Top 8 Players Gene Recombinant Protein Revenue (US$ Million) in 2024
 Figure 51. Asia-Pacific Gene Recombinant Protein Revenue (US$ Million) by Type (2020-2031)
 Figure 52. Asia-Pacific Gene Recombinant Protein Revenue (US$ Million) by Application (2020-2031)
 Figure 53. Indonesia Gene Recombinant Protein Revenue (2020-2031) & (US$ Million)
 Figure 54. Japan Gene Recombinant Protein Revenue (2020-2031) & (US$ Million)
 Figure 55. South Korea Gene Recombinant Protein Revenue (2020-2031) & (US$ Million)
 Figure 56. Australia Gene Recombinant Protein Revenue (2020-2031) & (US$ Million)
 Figure 57. India Gene Recombinant Protein Revenue (2020-2031) & (US$ Million)
 Figure 58. Indonesia Gene Recombinant Protein Revenue (2020-2031) & (US$ Million)
 Figure 59. Vietnam Gene Recombinant Protein Revenue (2020-2031) & (US$ Million)
 Figure 60. Malaysia Gene Recombinant Protein Revenue (2020-2031) & (US$ Million)
 Figure 61. Philippines Gene Recombinant Protein Revenue (2020-2031) & (US$ Million)
 Figure 62. Singapore Gene Recombinant Protein Revenue (2020-2031) & (US$ Million)
 Figure 63. Central and South America Gene Recombinant Protein Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Central and South America Top 5 Players Gene Recombinant Protein Revenue (US$ Million) in 2024
 Figure 65. Central and South America Gene Recombinant Protein Revenue (US$ Million) by Type (2020-2031)
 Figure 66. Central and South America Gene Recombinant Protein Revenue (US$ Million) by Application (2020-2031)
 Figure 67. Brazil Gene Recombinant Protein Revenue (2020-2025) & (US$ Million)
 Figure 68. Argentina Gene Recombinant Protein Revenue (2020-2025) & (US$ Million)
 Figure 69. Middle East and Africa Gene Recombinant Protein Revenue YoY (2020-2031) & (US$ Million)
 Figure 70. Middle East and Africa Top 5 Players Gene Recombinant Protein Revenue (US$ Million) in 2024
 Figure 71. South America Gene Recombinant Protein Revenue (US$ Million) by Type (2020-2031)
 Figure 72. Middle East and Africa Gene Recombinant Protein Revenue (US$ Million) by Application (2020-2031)
 Figure 73. GCC Countries Gene Recombinant Protein Revenue (2020-2025) & (US$ Million)
 Figure 74. Israel Gene Recombinant Protein Revenue (2020-2025) & (US$ Million)
 Figure 75. Egypt Gene Recombinant Protein Revenue (2020-2025) & (US$ Million)
 Figure 76. South Africa Gene Recombinant Protein Revenue (2020-2025) & (US$ Million)
 Figure 77. Gene Recombinant Protein Industry Chain Mapping
 Figure 78. Channels of Distribution (Direct Vs Distribution)
 Figure 79. Bottom-up and Top-down Approaches for This Report
 Figure 80. Data Triangulation
 Figure 81. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Recombinant Proteins Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Recombinant Protein Expression System Market Research Report 2024
Global Recombinant Protein Peptide Drug Market Research Report 2024
Global Recombinant Therapeutic Protein Market Research Report 2025
Global Recombinant Antibody Market Research Report 2025
Global Prokaryotic Recombinant Protein Market Research Report 2024
Global Recombinant Protein Industrial Reagents Market Research Report 2024
Recombinant Protein Research Reagents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Protein Vaccine Market Insights Forecast to 2030
Recombinant DNA Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Therapeutic Recombinant Protein Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Peptide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Influenza Vaccine Market Research Report 2024
Recombinant Protein Therapeutics Market
Global Recombinant Trypsin Market Insights Forecast to 2030
Global Recombinant Protein Biological Research Reagents Market Research Report 2024
Recombinant Albumin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Collagen for Cosmetics Market Research Report 2024
Global Alternative Protein Synthetic Biology Market Research Report 2024
Global Restructured Collagen for Skin Care Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions